CRP and COVID-19: Several cancer patient characteristics were found to be positively associated with risk of COVID-19 death: being of Asian ethnicity [as compared to white—HR: 3.73 (95% CI: 1.28–10.91)], receiving palliative treatment [as compared to no active treatment—HR: 5.74 (95% CI: 1.15–28.79)], time since cancer diagnosis >24 months [as compared to ≤24 months—HR: 2.14 (95% CI: 1.04–4.44)], presenting with dyspnea [as compared to no dyspnea—HR: 4.94 (95% CI: 1.99–12.25)], and having high CRP levels [3rd tertile vs. 1st tertile—HR: 10.35 (95% CI: 1.05–52.21)].